2026-07-02
No AI summary for this filing type
View Full Filing (SEC EDGAR)Cns Pharmaceuticals INC
-$222.6K
Net Activity
Data as of: 2026-03-31
Institutions Holding
11
Popularity Rank
#9601
Avg Weight
0.01%
Total Value
$348.7K
11 institutions currently hold CNSP, with 6 net buyers and 2 net sellers this quarter.
Institutional Moves (Q1 2026)
Significantly Increased
Based on recent trading activity
Net Selling Institutions
2
Net Buying Institutions
6
Top 5 by Value
Across its top 11 institutional holders, CNSP's holder base skews toward low-concentration, high-turnover investors on average (avg. concentration score 14/100, avg. turnover score 54/100).
+$206.3K
Total Buy Value
$81.0K
Total Sell Value
6
Net Buyers
2
Net Sellers
CNSP does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.
13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.
Terms of Use for AI
AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/CNSP
No Form 144 planned sale filings in the last 90 days
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
No AI summary for this filing type
View Full Filing (SEC EDGAR)18978H508
The most-added stocks by 13F institutions this quarter
Institutions Holding
6,153
Total reported value
$2.1T
3246 13F institutions increased their position this quarter
Institutions Holding
5,960
Total reported value
$1.5T
3030 13F institutions increased their position this quarter
Institutions Holding
5,769
Total reported value
$3.0T
2744 13F institutions increased their position this quarter
Access CNSP's institutional ownership data programmatically:
REST API
curl https://alphasmo.com/api/v1/market/stock/CNSPCLI
npx alphasmo stocks get CNSP